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Abstract
Phagocytosis is a fundamental cellular process that is pivotal for immunity as it coordinates
microbial killing, innate immune activation and antigen presentation. An essential step in this
process is phagosome acidification, which regulates a number of functions of these organelles that
allow them to participate in processes essential to both innate and adaptive immunity. Here we
report that acidification of phagosomes containing Gram-positive bacteria is regulated by the
NLRP3-inflammasome and caspase-1. Active caspase-1 accumulates on phagosomes and acts
locally to control the pH by modulating buffering by the NADPH oxidase NOX2. These data
provide insight into a mechanism by which innate immune signals can modify cellular defenses
and establish a new function for the NLRP3-inflammasome and caspase-1 in host defense.
A particularly important process in host defense is phagocytosis, the internalization of
particles into organelles called ‘phagosomes’ that restrict microbial replication and
participate in the presentation of antigens to prime T cell responses 1. Despite this crucial
role in immunity, the molecular mechanisms that regulate the functions of phagosomes
remain poorly understood. What is known is that phagosomes in macrophages are
dynamically remodelled during their ‘maturation’ by the sequential fission with early and
then late endosomes, and ultimately fusion with lysosomes 2-4. An important aspect of the
maturation process is vacuolar acidification, which regulates the activity of the pH-sensitive
enzymes that are delivered from lysosomes and required to digest internalized cargo 5. The
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ttimely delivery of microbes into a mature and acidified phagolysosome is essential not only
for microbial killing 6, but also to facilitate activation of certain innate immune signalling
pathways 7. Moreover, the rate of phagosome acidification also regulates antigen processing
and presentation by macrophages and dendritic cells (DCs) 8. Because of these pivotal roles
in immunity, understanding the mechanisms that allow the host to remodel phagosomal
compartments to optimize their microbicidal and hydrolytic activity is of fundamental
importance.
Acidification is key to many facets of phagosome function. It is a regulated process that
begins almost immediately after the phagocytic cup has closed 9,10 and, for certain cargo,
the luminal pH can drop from 7 to 4 in a matter of minutes. These rapid changes precede the
fusion with acidic compartments and instead early acidification requires delivery of the
vacuolar-H+-ATPase (V-ATPase)11. This proton transporting holoenzyme is recruited from
endosomes and lysosomes, and assembled on the membrane of the nascent vacuole 9,12.
However, how the pH is then regulated remains poorly defined. V-ATPase activity in
mammalian macrophages and DCs can be ‘primed’ by innate immune stimuli, through a
process that appears to require transcriptional regulation 13,14. Additionally, the NADPH
oxidase has been suggested to counteract the V-ATPase and neutralize the phagosome pH in
certain cells 15. A number of pathogens have evolved mechanisms to evade these processes,
including buffering their local environment in an attempt to maintain a beneficial neutral
pH.
The nature of the mature phagosome is therefore determined by the complex interplay
between the internalized microbe and the rapid remodeling of the organelle by the host in
response to the different cargo. The observation that Toll-like receptors (TLRs) are recruited
to some phagosomes 16-18 led to the proposal that phagosome-associated TLRs might survey
the luminal contents and control vacuole maturation in a cargo-dependent and organelle
autonomous manner to mediate these rapid changes19,20. Although attractive as a
mechanism for sensing and remodeling the phagosome depending on the type of internalized
material, this function of the TLRs remains controversial, especially as the molecular details
of how they might regulate this process remains obscure 20. The rapidity of the changes that
occur after microbial engulfment argues against the fate of the phagosome being controlled
at a transcriptional level. Rather we reasoned that local, post-translational modifications
induced by innate immune signals were more likely to underlie the prompt remodeling of
the phagosome that occurs after internalization of different microbes. To investigate this
possibility, we chose to focus on the inflammasome, as it is an innate immune pathway
whose terminal effectors are proteases that can rapidly modify select host components. We
found that caspase-1 is rapidly activated upon phagocytosis of Gram-positive microbes.
Moreover, we demonstrate that activation of the NLRP3 inflammasome and its effector,
caspase-1, are instrumental in enabling the microbicidal activity of Staphylococcus aureus-
containing phagosomes. Caspase-1 acts on the NADPH oxidase (NOX2), and by controlling
its activity it modifies the pH of the vacuole. These findings identify an essential role of
caspase-1 in locally coordinating the environment of phagosomes. We propose that this cell
autonomous defense function of caspase-1 acts in concert with its role in pro-inflammatory
cytokine release and pyroptosis and thus positions it as a master regulator of innate
immunity.
Results
Caspase-1 accumulates on phagosomes containing S. aureus
Infection with Gram-positive microbes causes assembly of the NLRP3 inflammasome and
activation of caspase-121. While investigating inflammasome activation during S. aureus
phagocytosis we observed that total caspase-1, monitored by using either an anti-caspase-1
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tantibody in bone marrow derived macrophages (Figure 1a) or by transfection of RFP-
caspase-1 into RAW 264.7 cells (Figure 1b), was found not only in the cytosol but was also
enriched on phagosomes. Caspase-1 exists as both an inactive pro-enzyme and, after auto-
proteolytic cleavage in an inflammasome platform, an active protease. As these methods
could not distinguish pro-caspase-1 from active caspase-1 we used the Fluorescent Labelled
Inhibitor of Caspases (FLICA) reagent, which forms a covalent bond with the active
protease 22, to determine the localization of active caspase-1 (Figure 1c-f). Active caspase-1
accumulated around bacterial phagosomes (Figure 1c). The FLICA staining required
internalization of S. aureus as it was blocked by cytochalasin D (Figure 1d). The localization
of caspase-1 after S. aureus phagocytosis contrasted with the widespread cytoplasmic
distribution of active caspase-1 seen following treatment with LPS and ATP, a non-
particulate activator of the NLRP3 inflammasome (Figure 1e). The accumulation of active
caspase-1 on phagosomes was cargo-dependent; latex bead phagosomes did not stain with
FLICA, despite the presence of total caspase-1 as detected by antibody staining
(Supplementary Fig. 1a-c) and phagocytosis of the Gram-negative bacterium Escherichia
coli was not associated with detectable caspase-1 activation in unprimed cells
(Supplementary Figure 1d,e). Together these data indicate that caspase-1 was activated and
then specifically recruited to S. aureus phagosomes.
Caspase-1 activation triggered by S. aureus phagocytosis
We next sought to better define what regulated caspase-1 activation after S. aureus
phagocytosis. Activation was dependent on the NLRP3 inflammasome, as cells deficient in
Ice (caspase-1), or the inflammasome components Asc and Nlrp3 all failed to activate
caspase-1 as measured by flow cytometry (Figure 2a). A similar reduction of FLICA
staining was observed when confocal microscopy was used to assess both the total FLICA
staining and the amount of phagosome-associated active caspase-1 (Figure 2b). These data
confirmed that the FLICA staining was specific and indicated that the inflammasome was
required for the phagosome-associated caspase-1.
To establish the kinetics of this activation we monitored the generation of mature caspase-1
p10 by immunoblotting (Figure 2c). Although caspase-1 could not be detected in cell
supernatants at early time points, we did observe the appearance of caspase-1 p10 in cell
lysates as early as 15 minutes after internalization of bacteria (Figure 2c). To further define
the kinetics, we used flow cytometry to monitor YVAD-FLICA. Phagocytosis of both live
and heat-inactivated (HI) S. aureus was associated with early caspase-1 activation (within 15
minutes of internalization) (Figure 2d). Early caspase-1 activation did not require priming
initiated by NF-κB as it was not blocked by the inhibitors BAY 11-7085 or QNZ (Figure
2e). Similarly, it did not require TLR signaling as it was unimpaired in Myd88−/− Trif−/−
cells (Figure 2f). Early caspase-1 activation was also not attenuated by Bafilomycin A, an
inhibitor of the V-ATPase, indicating that vacuolar acidification did not play a role at this
early point (Figure 2g-h). Instead we observed that phagocytosis of S. aureus was associated
with generation of reactive oxygen species (ROS) (Figure 2g), which contributed to
caspase-1 activation as demonstrated by reduced activation in the presence of low dose
diphenylene iodonium (DPI), an inhibitor of ROS (Figure 2h). However, and consistent with
previous reports, caspase-1 activation was normal in gp91-phox deficient macrophages
indicating that the source of the ROS that activates the inflammasome was not the phagocyte
oxidase (NOX2) (Supplementary Figure 2a). Notably, addition of DPI, either alone or with
Bafilomycin A, did not completely block caspase-1 activation indicating that there are other
additional, but currently unidentified factors, that contribute to activate the inflammasome
early during phagocytosis. Unlike S. aureus, internalization of E. coli was associated with
minimal ROS (Figure 2i) and negligible early caspase-1 activation (Figure 2j). Further
arguing against a role for ROS in early E. coli phagocytosis, addition of DPI had no effect
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ton the small amounts of caspase-1 activation observed with E. coli uptake (Figure 2j). Thus
phagocytosis triggered ROS and early caspase-1 activation occurs during the uptake of
select microbes.
In contrast, late or sustained caspase-1 activation (>1 hour after infection) was observed
only with live and not heat killed S. aureus, (Figure 2d and Supplementary Figure 2b)
suggesting that factors associated with viable bacteria stabilize inflammasome activity,
resulting in both increased duration and amplitude of the signal. Consistent with previous
reports, S. aureus internalization only led to IL-1β release at later time points if the bacteria
were both viable and virulent as HI S. aureus or the Sar / Agr mutants that fail to express
virulence factors did not induce the late caspase-1 and IL-1β release (Supplementary Figure
2b,c). The sustained activation of caspase-1 and IL-1β release required internalization of
bacteria because it could be blocked by Cytochalasin D (Figure 2k,l, Supplementary Fig.
2d). Late caspase-1 activation and IL-1β release was also partially dependent on the proton
pump and vacuolar acidification as it was attenuated by the addition of Bafilomycin A
(Figure 2k,l and Supplementary Figure 2d). Together these data indicate that caspase-1
activation begins immediately after internalization of S. aureus, and suggest that early
NLRP3 inflammasome activation is triggered by events such as ROS production that are
associated with the phagocytic process.
Caspase-1 regulates phagosome pH
To address the physiological relevance of phagocytosis-associated caspase-1 activation we
chose to focus on acidification, as this is an important regulator of many functions of
phagosomes. The pH of phagosomes containing certain live bacteria including S. aureus is
actively neutralized by the microbes they contain 23 (Supplementary Fig. 3a), complicating
their use to measure phagosome acidification. Therefore we first measured acidification
using HI bacteria which are unable to neutralize the phagosome. For this purpose the rate of
acidification was monitored using a highly sensitive and accurate ratiometric assay (Figure
3a,b) in cells pretreated with either a pan-caspase (ZVAD) or caspase-1 specific inhibitor
(YVAD). Both ZVAD and YVAD inhibited acidification of S. aureus containing vacuoles in
a dose-dependent manner (Figure 3b). Similar results were observed when pH was measured
by quantifying delivery of pHrodo™ S. aureus into acidic compartments (Figure 3c).
Caspase inhibition reduced phagosome acidification in all macrophages tested including
bone marrow-derived macrophages, peritoneal macrophages, and the macrophage cell lines
J774.1 and RAW 264.7 (Figure 3d). Additionally, ZVAD also retarded acidification of
phagosomes containing live bacteria (Supplementary Figure 3b).
The kinetics of acidification in the absence of caspase-1 (Supplementary Figure 3c,d)
suggested that caspase-1 regulated early acidification and hence was unlikely to act by
modifying later steps such as phagosome-lysosome fusion. As an alternative, we explored
whether caspase-1 might directly regulate the accumulation of protons in S. aureus
phagosomes. To test this we used a phagosome pH dissipation assay 24,25 (Supplementary
Figure 3e). This assay can estimate the dynamic regulation of pH by monitoring the acute
changes induced after pharmacological manipulation of macrophages containing
phagosomes that have already acidified. As an example, and similar to previous reports
using other bacteria 9,24, acute blockade of the V-ATPase with Bafilomycin A resulted in
rapid and total dissipation of the phagosome pH (Figure 3e), confirming that the pH of the S.
aureus phagosome required the activity of the V-ATPase and that this assay was able to
measure proton concentration in the phagosome in real-time. Addition of ZVAD (data not
shown) and YVAD (Figure 3f) resulted in partial dissipation of the pH of phagosomes
containing both live and HI S. aureus. The data from these dissipation assays along with the
kinetics argue against caspase-1 regulating the fusion of phagosomes with lysosomes, as this
would occur later and not be acutely reversible with any treatment. Rather these data suggest
Sokolovska et al. Page 4
Nat Immunol. Author manuscript; available in PMC 2013 December 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tthat caspase-1 acts to directly control the rate of accumulation of protons in the lumen of the
organelle.
The NLRP3 inflammasome regulates phagosome pH
To better define the upstream events that trigger the early caspase-1 activation that regulates
phagosome acidification we used macrophages from mice with targeted deletions of genes
in the caspase-1 regulation pathway. Similar to macrophages treated with caspase inhibitors
(Figure 3), bone marrow-derived macrophages that lacked caspase-1 (Ice−/−) also showed
impaired phagosome acidification (Figure 4a). Furthermore, Nlrp3−/− and Asc−/− bone
marrow-derived macrophages showed impaired phagosome acidification (Figure 4b,c),
confirming that the NLRP3 inflammasome was upstream of caspase-1 in this context. In
contrast, macrophages from 129P3/J and 129x1/SvJ mice that lack caspase-11 showed no
defect in phagosome acidification (Figure 4d) excluding any potential involvement of
caspase-11, which is also deficient in Ice−/− mice. This defect in acidification was specific
for S. aureus and not E. coli as these phagosomes acidified normally in Ice−/−, Nlrp3−/− and
Asc−/− cells (Figure 4e,f). These data also confirmed that there was no global abnormality in
the endolysosome compartment of inflammasome deficient cells.
As previous work has implicated TLRs in regulating phagosome maturation we also tested if
TLRs were required for acidification. Tlr2−/− and Myd88−/− macrophages not only
phagocytosed S. aureus normally, but also acidified S. aureus-containing phagosomes with
kinetics comparable to that of WT cells (Figure 4g). Similarly, neither TLR adaptors TRIF
and Myd88 were required as no defect in acidification was observed in the Trif−/− Myd88−/−
cells (Figure 4h) nor did TLR priming accelerate acidification (Supplementary Figure 4).
These data indicate that TLRs do not play a role in regulating this process and militate
against the retarded acidification being due to loss of the autocrine action of IL-1β as Myd88
is the common adaptor for these receptors. Together these data confirm that the NLRP3
inflammasome and caspase-1 regulate the pH of phagosomes, and thus identify a new role
for caspase-1 in cellular processes.
Caspase-1 has phagosome-associated substrates that regulate pH
Phagosomes are complex intracellular compartments containing over 3000 different types of
protein 26. Caspase-1 has proteolytic activity and the observation that it accumulates on
phagosomes raised the possibility that it might act locally to modify the pH and microbicidal
activity by directly cleaving target proteins on the organelle. To investigate how caspase-1
might control the pH we performed a bioinformatic analysis of previously identified
phagosome-associated proteins 26. This search found over 300 proteins that had potential
caspase-1 cleavage sites (Supplementary Table 1), thus identifying the candidates that might
be cleaved on the phagosome after inflammasome activation to regulate the pH.
One particularly relevant set of substrates were the subunits of the NOX2 complex. In
certain cells phagosomes are buffered by the phagocyte NADPH oxidase, NOX2, which
generates hydroxyl groups that actively alkalinize the lumen and counteract the V-ATPase.
Further analysis of the NOX2 complex identified that the potential caspase-1 cleavage sites
were restricted to the cytosolic aspect of the complex and hence would be accessible to the
activity of the protease (Supplementary Figure 5a). This includes Rac, which is an
important, regulated component of NOX2 and indeed both Rac1 and Rac2 have previously
been identified as caspase substrates 27,28. Confirming the potential for caspase-1 to process
this component of the NOX2 complex, a cleaved fragment was detected when Rac was
incubated with caspase-1 (Figure 5a). As the p67-phox interaction site is at the NH2-
terminus, this processing would be predicted to disrupt the ability of Rac to interact with this
component of the oxidase (Supplementary Figure 5b).
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phox, the catalytic subunit of NOX2. To further explore whether gp91-phox might be a
target of caspase-1 we first performed in silco cleavage using the SitePrediction algorithm
(Supplementary Figure 5a,b). This identified 11 potential caspase-1 cleavage sites, including
a high confidence site (>99.9% probability) at D388. All of the sites in gp91-phox were
cytosolic and hence potentially available to caspase-1 that was recruited to the phagosome.
Many of the cleavage sites were within the COOH-terminus and would be predicted to
dissociate the FAD and NADPH binding domains from the transmembrane domain, and
hence disrupt the activity of the oxidase. To determine whether caspase-1 might process
gp91 we first isolated membrane fractions and performed in vitro digestion (Figure 5b).
gp91-phox is a complex protein that undergoes multiple post-translational modifications
during its generation. In addition to recognizing full-length gp91-phox, which runs as a
smear due to its heavy glycosylation, the anti-gp91-phox antibody (mAb 54.1) also
recognizes immature forms of gp91 and fragments that have been attributed to the cleavage
by intracellular proteases29,30 thus resulting in the complex banding pattern observed by
immunoblotting (Figure 5b-d and Supplementary Figure 5d-f). Nonetheless, we observed
that addition of recombinant caspase-1 generated several new fragments suggesting that
hydrolysis might occur at multiple sites (Figure 5b). Processing required the enzymatic
activity of caspase-1, as it was blocked by the addition of YVAD (Figure 5b) and by heat
inactivation of the protease (Supplementary Figure 5e).
Processing at the highest confidence caspase-1 cleavage site (D388) would be predicted to
destroy the epitope recognized by mAb 54.1 that has been mapped to amino acids 383-390
31 (Supplementary Figure 5c). Therefore, to determine if processing occurred in vivo during
infection, we took advantage of this property of 54.1 and monitored for loss of signal by
immunoblot as a specific indicator of caspase-1 cleavage at D388. Consistent with
endogenous processing of gp91-phox by caspase-1, infection of macrophages with S. aureus
and Group B Streptococcus resulted in loss of the gp91 signal (Figure 5c). This was not due
to bacterial-derived proteases from S. aureus as this loss was also seen in B. subtilis and
Group B Streptococcus (Supplementary Figure 5f). However, this loss of signal was
dependent on caspase-1, as it was not observed in caspase-1 deficient cells (Figure 5e).
Taken together, these data suggest that caspase-1 might negatively regulate the NOX2
complex through hydrolysis of one or more of its subunits.
Based on our observation that caspase-1 can hydrolyse components of the NOX2 complex
we hypothesized that a functional consequence of phagosome-associated caspase-1 might be
to restrict NOX2 activity and ROS production in the phagosome and hence control vacuolar
pH. To assess this we monitored ROS production in wild-type macrophages and
macrophages deficient in inflammasome components after infection (Figure 5e-h). In wild
type cells, the total cellular ROS induced by phagocytosis of S. aureus was also associated
with a small but transient increase immediately following internalization (Figure 5e). In
contrast, cells deficient in the inflammasome components all showed increased ROS activity
(Figure 5e). To identify the source of this increased ROS we used a ratiometric assay and
measured phagosome-associated ROS. Wild type cells showed only low levels of
phagosome-associated ROS (Figure 5f-h), whereas Nlrp3−/−, Ice−/− and Asc−/− cells all had
greatly increased phagosome-associated ROS that persisted for 2 hours after internalization.
Together these data indicate that the inflammasome can negatively regulate the levels of
ROS in the lumen of the phagosome to modify the buffering capacity of the organelle, and
we speculate that this is through its ability to hydrolyse components of the NOX2 complex.
The levels of ROS inversely correlated with the luminal pH when measured simultaneously
in the same cells (Figure 5g) and were in keeping with caspase-1 regulating pH by
modulating the buffering in the phagosome. To further evaluate this possibility, we
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tneutralized the oxidase by the addition of DPI and measured the pH in wild type and
inflammasome deficient cells. Addition of DPI at levels that totally blocked phagosome-
associated ROS production (Figure 5i), partially rescued the defect in acidification in the
Nlrp3−/−, Ice−/− and Asc−/− deficient cells (Figure 5i). These observations were consistent
with inflammasome activation promoting acidification by decreasing buffering by the
NADPH oxidase. However, despite complete inhibition of ROS, there remained a residual
defect in acidification in the inflammasome deficient cells (Figure 5i) indicating that the
ability of caspase-1 to modify other factors such as the V-ATPase might also be involved in
how it controls the phagosome pH.
Caspase-1 regulates the pH of Gram-positive phagosomes
To establish if our model derived from studies of S. aureus phagosomes could be applied
more broadly, we tested whether caspase-1 was involved in phagocytic processes after
uptake of Gram-positive and Gram-negative bacteria. Unlike S. aureus early caspase-1
activation was not triggered during E. coli phagocytosis (Figure 2j and 6a,b). This was not
due to a failure of phagocytosis as the internalization of E. coli into macrophages was
confirmed by confocal microscopy (Supplementary Figure 1d,e). To further define which
bacteria were associated with early caspase-1 activation we screened a panel of Gram-
positive and Gram-negative microbes for their ability to induce FLICA staining using flow
cytometry. Early caspase-1 activation was associated with internalization of all of the Gram-
positive but none of the Gram-negative microbes (Figure 6c). We next tested the role of
caspase-1 in regulating the activity of these different phagosomes. Phagosomes containing
the Gram-positive microbes failed to acidify in macrophages that could not activate
caspase-1 (Figure 6d). In contrast no defects in acidification were observed when
phagosomes contained Gram-negative microbes (Figure 6e). Together these data indicate
that the role of caspase-1 in phagosome acidification is cargo dependent, and that it plays an
important role in controlling the intracellular fate of the Gram-positive but not Gram-
negative bacteria that were tested.
Our data suggested that an important mechanism by which caspase-1 regulates the pH was
by controlling the NADPH oxidase, in particular by terminating ROS generation in
phagosomes. Conversely, we reasoned that phagocytosis of particles that do not induce
phagosomal ROS would not require caspase-1 activation to acidify. Therefore, to establish
whether the requirement for caspase-1 activation correlated with the amount of ROS
generated we screened for its production during phagocytosis of our Gram-positive and
Gram-negative bacteria. ROS was induced strongly after phagocytosis of S. aureus, Bacillus
subtilis and Group B streptococcus (Figure 6f). In contrast E. coli K12, Citrobacter
rodentium and Enterobacter cloacae all induced minimal ROS (Figure 6f). Taken together
these data are consistent with a model in which phagosome-associated caspase-1 is required
for vacuolar acidification during internalization of Gram-positive bacteria as it counteracts
the buffering activity of the NOX2 complex. In contrast, phagocytosis of Gram-negative
bacteria is not associated with ROS and these phagosomes can acidify independently of
caspase-1 (Supplementary Figure 6).
The NLRP3 inflammasome regulates phagosome function
We next sought to determine the impact that the regulation of pH by phagosome-associated
caspase-1 might have on the function of these organelles. We first validated that bacterial
internalization was normal in inflammasome deficient cells using a flow cytometry based
assay (Figure 7a,b). These data confirmed that equivalent levels of internalization of bacteria
occurred in cells of all genotypes when infected at either low or high multiplicity of
infections (MOIs). To ensure that this assay was not simply measuring binding, bacterial
internalization was also confirmed both by confocal microscopy (data not shown) and EM
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t(Supplementary Figure 7). Acidification is essential for activation of the hydrolytic enzymes
required for microbial killing. EM examination of macrophages 8 hours after infection
suggested increased intra-vacuolar replication of S. aureus and increased escape of bacteria
from the phagosome lumen into the cytosol (Figure 7c). To quantify whether these
observations correlated with a failure to control the replication of bacteria in phagosomes,
we performed gentamicin protection assays. These assays confirmed that the failure to
activate caspase-1 not only led to a defect in phagosome acidification but also impaired the
ability of macrophages to kill internalized S. aureus as more viable bacteria were recovered
from both NLRP3 and caspase-1 deficient cells (Figure 7d). We have previously reported
that the IL-6 response to S. aureus requires phagosome acidification32 (Figure 7e) and hence
we used production of this cytokine as another functional readout of the ability of the
inflammasome to control phagosome pH. Consistent with a failure of phagosome
acidification in the absence of caspase-1, treatment of macrophages with YVAD blocked
production of IL-6 in response to S. aureus (Figure 7f). Similarly, Ice−/− macrophages also
showed impaired IL-6 secretion (Figure 7g). As a final test of the functionality of the
phagosomes we measured antigen presentation. Cross-presentation of phagocytosed antigens
to CD8 T cells is thought to occur primarily from an early and non-acidified
phagosome8,15,33. However, macrophages normally rapidly deliver antigens into acidic
phagosomes and hence degrade internalized material, preventing cross-presentation. We
therefore tested if inflammasome activation might antagonize the ability of phagosomes to
cross-present antigens by favouring phagosome acidification. To test the cross-presentation
of ovalbumin to ovalbumin-specific OT-I CD8 T cells, we measured T cell proliferation
after ovalbumin was delivered to macrophages either as a soluble protein or coupled to
beads that do not activate the inflammasome or coupled to S. aureus. WT and Ice−/−
macrophages demonstrated equivalent ability to cross-present when ovalbumin was
delivered in the absence of inflammasome activation indicating that there is no intrinsic
difference in these cells (Figure 7h,i). Consistent with caspase-1 activation favouring
acidification and preventing cross-presentation, WT macrophages failed to cross-present
ovalbumin when delivered on S. aureus. In contrast, macrophages that could not activate the
inflammasome (i.e. WT cells treated with YVAD and Ice−/− macrophages) retained the
ability to cross-present ovalbumin delivered on S. aureus (Figure 7h,i). Thus caspase-1
activation negatively impacts cross-presentation and we speculate that this is by accelerating
delivery of antigen into a degradative compartment. Taken together, these data demonstrate
the profound impact that the NLRP3 inflammasome and caspase-1 can have on phagosome
function and exhibit how their ability to control the pH of phagosomes impacts a number of
cell-intrinsic processes important for innate and adaptive immunity.
Discussion
Much of the recent focus in innate immunity has been on the role of caspase-1 in regulating
inflammatory cytokine production, with relatively little consideration for its potential to
impact other innate immune processes. Nonetheless, emerging functions for caspase-1 that
are independent of IL-1β and IL-18 processing, implicate this protease as a regulator of
other aspects of immunity. These include unconventional protein secretion 34, activation of
sterol regulatory element binding proteins 35, restriction of intracellular pathogen
replication 36-38 and induction of a pro-inflammatory form of cell death termed
pyroptosis 39,40. Here we identify another function of caspase-1: to regulate phagosome pH.
The pH of vacuoles controls many of the processes involved in antimicrobial defense
including antigen processing and presentation 15, microbial killing 4, and TLR
signalling 32,41-43. For these reasons, the role of caspase-1 activation in regulating the pH is
undoubtedly an important, but hitherto unrecognized, aspect of its role in host defense.
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causing rapid but locally restricted post-translational modification of the proteins associated
with the organelle. Specifically, the accumulation of caspase-1 on phagosomes allows its
proteolytic activity to directly modify components of the organelle. However, it is unlikely
that there is a single target that is sufficient to fully account for the caspase-1 phenotype.
Moreover, even in the NOX2 complex, the existence of multiple sites in multiple
components suggest that it would not be feasible to generate a caspase-1-resistant NOX2
complex, or recapitulate the caspase-1 deficient phenotype, using a mutagenesis approach.
This targeting of multiple interacting substrates is reminiscent of findings with apoptotic
caspases which have been shown in global proteomic analysis to preferentially cleave
substrates that physically interact either in protein complexes or networks 44. The dimeric
nature of caspases is thought to explain the predilection of these proteases to target multiple
proteins in a complex.
The ability of ROS to buffer the phagosome pH has been shown in dendritic cells where it is
suggested to regulate antigen-processing 15,33. Our studies extend these findings to
demonstrate that ROS can also buffer phagosomes in macrophages and, furthermore, we
show that this is relevant to certain microbial cargo and can be regulated by innate immune
signals. NOX2 controls the phagosome environment as it is both the source of the ROS in
the vacuole and a substrate for caspase-1. In contrast to its role in buffering pH, the role of
NOX2 in activating the inflammasome is less clear. Consistent with previous reports that
concluded that the source of the ROS that triggers the inflammasome is not the phagocyte
oxidase, NOX2, 45 gp91-phox deficient cells retain the ability to activate caspase-1 early
after phagocytosis. Instead it has been proposed that the ROS that initiates inflammasome
activation is produced in a non-phagosomal compartment, such as mitochondria 46. Our data
outline an intricate relationship between the NLRP3 inflammasome and ROS, but also
suggest that at least two separate sources of ROS are likely to be involved; one that acts as
an initiator of inflammasome activation and another, NOX2, which is a local substrate of
caspase-1 on the phagosome that modifies the pH. We propose that the requirement for
caspase-1 in acidification segregates with ROS production during phagocytosis, not because
ROS is required to activate the inflammasome, but rather because NOX2 buffers the pH of
certain phagosomes and in these cases must be targeted by caspase-1 for acidification to
proceed.
Consistent with our work identifying a role for caspase-1 in regulating the pH of
phagosomes containing Gram-positive microbes, it is notable that previous work has
implicated the inflammasome in restricting replication of Mycobacterium tuberculosis 36. In
contrast, phagosomes containing Gram-negative bacteria do not demonstrate the same
dependence on caspase-1 for phagosome acidification, indicating that the ability of
caspase-1 to regulate phagosome pH is cargo dependent. We propose that the paucity of
ROS after Gram-negative phagocytosis obviates the need for caspase-1, as it is not required
to inactivate the oxidase in the vacuole for acidification to occur. This simple difference
explains why Gram-positive phagosomes must be accompanied by caspase-1 activation for
complete acidification to occur whereas Gram-negative phagosomes can acidify
independently of caspase-1. Nonetheless, maturation of Gram-negative phagosomes is a
regulated process and, as an example, caspase-11 regulates maturation of Legionella
vacuoles through a mechanism distinct from that described herein 37,38,47. It is evident
therefore that there are multiple mechanisms that control different aspects of phagosome
maturation, and that the relative importance of each is determined in part by the nature of the
microbial cargo.
Whether caspase-1 similarly regulates the intracellular fate of non-microbial NLRP3
agonists remains to be determined, but the potential is enticing and would provide new
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tperspectives on the role of the NLRP3-inflammasome in sterile inflammation. Finally, these
data raise the intriguing possibility that pathogens that block caspase activation 48 may do so
not simply to regulate the production of inflammatory cytokines but also to evade cellular
immunity by specifically perturbing the function of phagosomes, compartments that
otherwise restrict the intracellular replication of microbes and are crucial in initiating both
innate and adaptive immune responses.
METHODS
Mice and Cell Culture
C57BL/6J, B6.129S6-Cybbtm1Din/J, 129X1/SvJ and 129P3/J mice were from Jackson
Laboratory (Bar Harbor, ME). Myd88−/− mice were from M. Freeman (MGH, MA), OT-I
transgenic mice (B6.129S6-Rag2tm1FwaTg(TcraTcrb)1100Mjb) were from J.R. Mora (MGH,
MA) and Tlr2 −/− mice were from R. Medzhitov (Yale University School of Medicine, CT).
Mice were handled under a protocol approved by the Subcommittee on Research Animal
Care at MGH.
Thioglycollate-elicited peritoneal macrophages and Bone Marrow-derived (BM)
macrophages were grown as described 32,49. Immortalized WT, Ice−/−, Asc−/−, Nlrp3−/− and
MyD88/TRIF−/− BM macrophage cell lines were cultured as described 50-52. HEK293T,
J774.1 and RAW 264.7 cell lines (ATCC) were maintained according to ATCC’s
recommendations.
Typically macrophages were pre-chilled for 15 min on ice in media with 1% FBS before
adding bacteria. Bacterial clusters were disrupted by repeated passage through a 30-gauge
needle. Cells with bacteria were kept on ice for 30-40 min allowing the synchronization of
phagocytosis. Macrophages were then incubated at 37°C for the indicated times.
Bacteria
S. aureus Reynolds strain capsular serotype 5 (Cp5) (JC Lee, Brigham and Women’s
Hospital, MA), S. aureus Newman strain and isogenic mutants (ΔAgr, ΔSar, Δ Agr/Sar) (F.
Ausubel, MGH, MA), and Group B Streptococci (strain GBS type III COH-1; M. Wessels,
Boston Children’s Hospital, MA) were grown as described 32. B. subtilis, C. rodentum, E.
cloacae (K. Fitzgerald, University of Massachusetts, MA) and E. coli (strain K12; ATCC)
were grown at 37°C in LB medium overnight. When noted bacteria were heat-inactivated
(HI) at 65°C for 30 min. Bacteria labelling was as described 49,53.
Phagocytosis and phagosome acidification assays were performed as described 49. In
some cases, before adding bacteria, macrophages were pretreated for 1h with Bafilomycin A
(Sigma-Aldrich, 100 nM) or Cytochalasin D (Sigma-Aldrich, 10 μM) or for 2h with YVAD
or ZVAD inhibitors (Calbiochem). Where noted BM macrophages were pretreated with
Ultrapure LPS (E. coli 0111:B4, Invivogen, 100 ng/ml) for 3 h and ATP (Sigma-Aldrich, 5
mM) for 15 min before placing cells on ice. ATP was washed from the cells together with
bacteria after incubation for 5 min in a 37°C water bath.
Phagosome dissipation assays were modified from previously described protocols 9,23.
Macrophages were treated as above and indicated inhibitors were added after 30 min of
phagosome acidification. Equivalent amounts of DMSO were used as a vehicle control.
Cells were collected, washed and analyzed as described above 1, 5, 15 and 60 min after
adding the inhibitors.
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tTotal ROS production
Macrophages were loaded with H2DCFDA (Invitrogen, 10 μM) in medium with 1% FBS
for 40 min at 37°C. Cells were chilled for 15 min on ice and bacteria were added (MOI 50).
Cells were centrifuged at 515 × g for 4 min and incubated at 37°C for the indicated period of
time. Cells were washed, detached and immediately analyzed by flow cytometry to
determine MFI of H2DCFDA. Where noted, the ROS inhibitor Diphenyleneiodonium
chloride (DPI, Sigma-Aldrich, 2 or 5μM) was added to the wells 10 min before incubation
on ice.
Measurement of ROS production in the phagosome was adapted 53 and where noted
macrophages were pretreated for 1h with Bafilomycin A (100 nM) and 10 min with DPI
(5mM).
Caspase-1 activation by FACS and Western Blot
For FACS-based monitoring of caspase-1 activation live or HI S. aureus Reynolds CP5+
(MOI 50) or latex beads (Polysciences, 20 beads per cell) were added to cells, and following
synchronization were incubated at 37°C for the indicated periods of time. Cells were washed
and media was replaced with Fluorochrome-Labeled Inhibitors of Caspase-1 (FLICA, FAM-
YVAD-FMK) reagent (Immunochemistry) and incubated for 1h. Caspase-1 should be active
first before labeling with FLICA as addition of FLICA inhibits all subsequent caspase-1
activation. Next, cells were washed and analyzed live by FACS. In some experiments cells
were pretreated with Bafilomycin A (100 nM) or Cytochalasin D (10 μM) for 1h; DPI (2
μM) for 10 min; or Bay11-7085 (Sigma-Aldrich, 20 μM) or NF-κB Activation Inhibitor 6-
Amino-4-(4-phenoxyphenylethylamino) quinazoline (QNZ, Calbiochem, 100nM) for 30 min
before placing cells on ice. Inhibitors were washed from the cells together with bacteria
before adding FLICA.
To monitor caspase-1 activation by Western blot, BM macrophages were infected with S.
aureus as indicated. Processing of caspase-1 was analyzed by immunoblotting of cell lysates
or supernatants using anti-caspase-1 P10 (M-20, Santa Cruz Biotechnology). Some western
blot images were cut and rearranged to remove irrelevant information; however, all lanes are
from the same blot with the same exposure and contrast.
Confocal imaging
For imaging of active caspase-1, BM macrophages were stimulated with live S. aureus or E.
coli (MOI 10) or with beads (10 or 20 beads per cell) for 30 min or 1h. Media was then
replaced with FAM-YVAD-FMK or SR-VAD-FMK and incubated for 1h. Cells were
washed and imaged live. Some cells were fixed in 4% PFA and cell membrane was stained
with Alexa Fluor 647-conjugated cholera toxin subunit B (ChTxB, Invitrogen). Cell nuclei
and bacterial DNA were stained with Hoescht 33342. Cells were imaged immediately as
FLICA staining is not stable after fixation and does not tolerate permeabilization. In some
experiments cells were pretreated with Cytochalasin D (10 μM) for 1h; LPS (100 ng/ml) for
3h and ATP (5 mM) for 15 min before FLICA addition.
RAW 264.7, transfected by Amaxa electroporation with RFP-caspase-1 (C285A) (C.
Stehlik, Northwestern University, IL) or BM macrophages were incubated with live S.
aureus Reynolds CP5+ (MOI 10) or latex beads (10 beads per cell) at 37°C for 30 min or 1h
following synchronization. For caspase-1 staining by antibody, BM macrophages were fixed
with 4% PFA, permeabilized, blocked and incubated overnight at 4°C in caspase-1 p10
antibody (M-20, 1:50). Cells were washed and incubated in secondary Alexa 546 goat anti-
rabbit antibody (1:250) for 1h at RT. Cells were washed, cell nuclei and bacteria DNA were
stained with Hoechst 33342.
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tCells were imaged using 40× objective (aperture 0.6) and 100× oil objective (aperture 1.4)
and Nikon Ti (Eclipse) inverted microscope with Ultraview Spinning Disc (CSU-X1)
confocal scanner (Perkin Elmer). Images were captured with an Orca-ER Camera using
Volocity (Perkin Elmer). Post-acquisition analysis was performed using Volocity software.
Electron Microscopy
Macrophages following synchronization on ice were loaded with live S. aureus (MOI 10) at
37°C for 1h. Cells were washed twice in PBS and further incubated for 7h. Electron
microscopy was performed by The Microscopy Core of the Program in Membrane Biology
at MGH using a JEOL 1011 transmission electron microscope at 80 kV with an AMT digital
imaging system (Advanced Microscopy Techniques, MA).
S. aureus survival in macrophages were performed as described 49.
Cytokine production in cell-culture supernatants was assayed using DuoSet ELISA (R&D
Systems).
Antigen cross-presentation
BM macrophages or WT or Ice−/− macrophage cell lines were incubated with soluble
ovalbumin (OVA) (0.5 mg/ml), 3μm OVA-coated latex beads (10 beads per cell) or OVA-
coated HI S. aureus (MOI 10) for 1h for antigen loading. In some experiments cells were
pretreated for 1h with YVAD inhibitor (100 mM). After 1h antigen and inhibitor were
washed, and macrophages were further co-cultured with CFSE-labeled OT-1 CD8+ T cells
for 3 days at a ratio of 1:4 (BMDM: T cells). Next, cells were labeled with CD8 antibody
and decrease of CFSE staining on CD8+ T cells was measured by FACS. CD8+ T cells were
isolated from spleens of OT-I transgenic mice using magnetic beads (Miltenyi Boitec, CA)
according to manufacturer’s protocol and stained with 5 mM CFSE for 10 min at RT. For
preparation of particulate antigen, OVA was conjugated to latex beads or HI S. aureus by
passive adsorption as described 54.
Rac and GP91-phox cleavage assays, in vivo processing and immunoblotting
HEK 293T cells were transfected with HA-Rac1 (E. Lemichez C3M INSERM U1065) with
Fugene (Roche) and lysates were used as substrates in a cleavage assay with recombinant
mouse caspase-1 (Biovision) as previously described 55. Samples were separated by SDS/
PAGE and followed by immunoblot analysis for anti-HA (16B12, Covance).
To test gp91-phox cleavage, cell membranes were isolated from BM macrophages and were
assayed as above using anti-gp91phox (54.1, Santa Cruz Biotechnology). In some
experiments recombinant caspase-1 was heat inactivated for 10 min at 95°C.
To test gp91-phox processing by caspase-1 in vivo, BM macrophages or WT or Ice−/−
macrophage cell lines were infected as indicated (MOI 50). Bacteria were added to cells,
centrifuged 515×g for 4 min and incubated at 37°C for indicated period of time. Cells were
washed and cell membranes were isolated. Samples were separated by SDS/PAGE and
immunoblotted with anti-gp91phox (54.1). Some western blot images were cut and
rearranged to remove irrelevant information; however, all lanes are from the same blot with
the same exposure and contrast.
Statistics
All data are typically presented as a pool of three experiments (mean ± s.e.m), or as a single
experiment representative of three or more independent experiments (mean ± s.d).
Treatment groups were compared using the paired Student’s t test.
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tFigure 1. Active caspase-1 is recruited to S. aureus phagosomes
a-b, The localization of total caspase-1 was determined 30 minutes after infection with S.
aureus (MOI: 10) in a, Bone-marrow derived macrophages (BMDM) stained with anti-
caspase-1 antibody (left) and cholera toxin (right) or b, RAW 264.7 macrophages
transfected with RFP-caspase-1. Caspase-1, red; Cell and bacterial DNA, white. c-f,
Localization of active caspase-1 in BMDMs was determined by staining with FLICA. c, left
panel, Live S. aureus (MOI: 10); middle panel, high magnification of phagosome-
associated active caspase-1 (YVAD-FLICA) staining and right panel, three-dimensional
rendering model of phagosome-associated active caspase-1. d, S. aureus (MOI: 10) with
Cytochalasin D (10 μM), e, Localization of active caspase-1 in response to LPS and ATP,
and f, control untreated cells. Cell nuclei and bacterial DNA were labeled with Hoechst
(white); plasma membrane was stained with Alexa-647-conjugated cholera toxin B (red);
and active caspase-1 with YVAD-FLICA reagent (green). Caspase-1 activation was
measured 1h post-infection by staining with FLICA for 1h. Data are representative of three
independent experiments.
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tFigure 2. Phagocytosis of S. aureus triggers early activation of the NLRP3 inflammasome and
caspase-1
a, Active caspase-1 was determined by staining with FLICA 15 min after S. aureus
internalization and measured by flow cytometry (live S. aureus MOI: 50) or b, left panels,
microscopy (live S. aureus MOI: 10) in WT BMDM cell lines and cells deficient in
inflammasome components; Green, active caspase-1 as measured by YVAD-FLICA. White,
nuclei and bacterial DNA. Scale bars in 40× panels represents 5.9μm and 100× panel
2.9μm. Right, quantification of the number of caspase-1 positive phagosomes calculated as
a percentage of total phagosomes in each cell type WT - 237 phagosomes, Ice−/− - 185
phagosomes, Nlrp3−/− - 157 phagosomes, Asc−/− −183 phagosomes. c, Kinetics of caspase-1
activation in response to live S. aureus (MOI: 100) was determined in BMDM by
immunoblot of Caspase-1 p10 in total cell lysates. d, Kinetics of caspase-1 activation in
response to S. aureus in BMDM was measured by flow cytometry after internalization of
live (black) and heat-inactivated (HI) (red) S. aureus (MOI: 50). The amount of caspase-1
activation was measured by the addition of YVAD-FLICA, which acts to both inhibit further
activation and label the protease that is active at the time of addition (Supplementary Figure
2e,f). The time indicates when FLICA was added to the cells after S. aureus uptake and then
incubated for a further 1 hour. Left panel % FLICA positive cells, right panel, total YVAD-
FLICA fluorescence. e-f, YVAD-FLICA activation in the presence of e, the NF-kB
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tinhibitors BAY 11-7085 (20 μM) and QNZ (100 nM) and f, in Myd88−/− Trif−/− cells. g,
Total cellular ROS production in control and live S. aureus (MOI: 50) infected BMDM
treated with Bafilomycin A (100 nM) and/or DPI (2μM). h, Early caspase-1 activation by
live S. aureus (MOI: 50) was measured by flow cytometry of YVAD-FLICA in BMDM
treated with Bafilomycin A (100 nM) and/or DPI (2μM). i, Total cellular ROS and j,
YVAD-FLICA activity induced by live S. aureus or E. coli (bacterial MOI: 50) uptake in
control BMDM or macrophages treated with DPI (2 μM). In g-j, Bafilomycin A was added
30 min and DPI was added 10 min prior to infection. ROS was measured at 15 minutes; and
FLICA was added at 15 min post-internalization for 1h. k, Peritoneal macrophages were
infected for 2h with live S. aureus (MOI: 25) in the presence or absence of the pan-caspase
inhibitor ZVAD (100 μM), Cytochalasin D (10 μM) and V-ATPase inhibitor Bafilomycin A
(100 nM). Late caspase-1 activation was determined by immunoblotting for caspase-1 p10
in the culture supernatants. l, Peritoneal macrophages were infected for 1h with live S.
aureus (MOI: 25) with or without Cytochalasin D (10 μM) or Bafilomycin A (100 nM) and
stained with FLICA for 1h. Late caspase activity was measured by FACS analysis of FLICA
labeled cells. Data are representative of three or more independent experiments (mean ±
s.d). * p<0.01, **p<0.001 by Student’s t-test.
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tFigure 3. Caspase-1 inhibition blocks the acidification of S. aureus-containing phagosomes
a, Kinetics of HI S. aureus phagosome acidification in peritoneal macrophages pre-treated
for 2h with ZVAD (100 μM). b-c, Phagosome pH in peritoneal macrophages was measured
1h after uptake of HI S. aureus with or without pre-treatment with pan-caspase inhibitor
ZVAD (μM; dark grey), caspase-1 inhibitor YVAD (μM; light grey) and Bafilomycin A
(100 nM; white bar). The pH was measured by a ratiometric assay (b) and using FACS
analysis of pHrodo bacteria (c). Data in a-c are from one experiment representative of three
(mean ± s.d.). d, The pH of the phagosomes containing HI S. aureus was measured in the
absence (black bars) and presence (white bars) of the pan-caspase inhibitor, ZVAD (200
μM) in BMDM, RAW 264.7 macrophages, peritoneal macrophages and J774.1 cells. *
p<0.01, **p<0.001 by Student’s t-test. e, pH of phagosomes containing HI (left panel) or
live (right panel) S. aureus was monitored in BMDM after the addition of Bafilomycin A
(400nM) or control vehicle (DMSO) at 30 minutes. f, pH of phagosomes containing HI (left
panel) and live (right panel) S. aureus was monitored in BMDM after addition of YVAD
(250μM) or control vehicle (DMSO) at 30 minutes. The pH of phagosomes after addition of
Bafilomycin A (400nM) at 30 and 90 minutes are shown as a positive control. Arrows
indicate the time of addition of the drugs. Data are representative of three independent
experiments (mean ± s.d).
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tFigure 4. The NLRP3 inflammasome regulates acidification of S. aureus phagosomes
a-d, The kinetics of acidification of HI S. aureus phagosomes in WT and Ice−/− (a), Nlrp3−/−
(b), Asc−/− (c) BMDM cell lines and 129P3/J and 129x1/SvJ (d) BMDM. Data from a pool
of three independent experiments (mean ± s.e.m). (WT, black lines; knockouts, red lines). e-
f, Acidification of HI S. aureus and E. coli phagosomes in WT, Ice−/−, Nlrp3−/− and Asc−/−
BMDM cell lines. g, Kinetics of acidification of HI S. aureus phagosomes in Myd88−/− and
Tlr2−/− BM macrophages. h, Kinetics of acidification of HI S. aureus and E. coli
phagosomes in WT and Myd88−/− Trif−/− BM macrophage cell lines. Phagosome pH 5 and
60 mins after internalization of S. aureus or E. coli in WT and Myd88−/− Trif−/− BM
macrophage cell lines . (a-c) Data are presented as a pool of three or more experiments
(mean ± s.e.m), (d-h) Data are representative of three or more independent experiments. *
p<0.01, **p<0.001 by Student’s t-test.
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tFigure 5. Caspase-1 has phagosome-associated substrates that regulate pH
a, Lysates from HEK293T cells expressing HA-Rac1WT, N17 and L61 mutants were
treated with recombinant caspase-1 and immunoblotted for HA. b, Membrane preparations
from BMDM were treated with recombinant caspase-1 and immunoblotted for gp91-phox.
Arrows in a and b, indicate the cleaved fragments of Rac and gp91-phox. c-d BMDM were
infected with S. aureus or Group B Streptococcus (MOI: 50) (c) and WT and Ice−/−
macrophage cell lines were infected with S. aureus (MOI: 50) (d, left panel) for the stated
times and membranes isolated and immunoblotted for gp91-phox. Arrows indicate loss of
gp91-phox signal due to epitope disruption. d, right panel, time course quantifying the
intensity of the 22-25 kDa band (marked with and asterisk in left panel) in WT (white bars)
and Ice−/− (black bars) cells. Data from a pool of three independent experiments (mean ±
s.e.m). e, Total ROS and f, Phagosome-associated ROS was measured in WT, Ice−/−, Asc−/−
and Nlrp3−/− BM macrophage cell lines after HI S. aureus (MOI: 10) phagocytosis. g,
Correlation of phagosome pH and ROS measured in the same cells. h, Phagosome ROS and
i, pH was measured in the presence and absence of DPI in WT, Ice−/−, Asc−/− and Nlrp3−/−
BM macrophage cell lines after phagocytosis of HI S. aureus. (d right panel) Data are
presented as a pool of three experiments (mean ± s.e.m). (a-h) Data are representative of
three independent experiments * p<0.01, **p<0.001 by Student’s t-test.
Sokolovska et al. Page 21
Nat Immunol. Author manuscript; available in PMC 2013 December 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 6. The NLRP3 inflammasome and caspase-1 regulate the pH of phagosomes containing
Gram-positive but not Gram-negative bacteria
a, Kinetics of caspase-1 activation in response to live S. aureus (MOI: 100) and E. coli
(MOI: 100) was determined in WT and Ice−/− macrophage cell lines by immunoblot of
Caspase-1 p10 in total cell lysates or cell supernatants. b, Kinetics of caspase-1 activation in
response to S. aureus (red) and E. coli (grey) in BMDM was measured by flow cytometry
(MOI: 50). c, YVAD-FLICA activity induced by uptake of live Gram-positive and Gram-
negative bacteria (MOI: 50). Upper panel, Total YVAD-FLICA fluorescence; lower panel,
flow cytometry histograms. FLICA was added at 15 min bacterial post-internalization for
1h. d-e Acidification of HI Gram-positive (d) and Gram-negative (e) bacteria-containing
phagosomes in WT, Ice−/−, Nlrp3−/− and Asc−/− BM macrophage cell lines. NLRP3
inflammasome components (Nlrp3, Asc and caspase-1) are shown in green and blue. f, Total
cellular ROS (H2DCFDA) induced by uptake of live Gram-positive or Gram-negative
(MOI: 50) bacteria. ROS was measured at 15 minutes post-internalization. Data are
representative of three independent experiments.
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tFigure 7. The impact of caspase-1 on the function of phagosomes
a-b, Quantification of bacterial uptake in WT and inflammasome deficient macrophage cell
lines at low and high MOIs. a, Percentage of phagocytic cells (left) and phagocytic index
(MFI of S. aureus positive cells) (right) of WT (black bar), Ice−/− (white bar) and Nlrp3−/−
(grey bar) macrophages treated with HI Alexa 647 labeled-S. aureus (MOI: 2) for 60
minutes. Mean +/-sem, n=3. b, Phagocytosis of WT (black bar) and Ice−/− (white bar)
macrophages treated with HI Alexa 647 labeled-S. aureus (MOI: 25) for 60 minutes. Mean
+/-sd of one representative experiment. The percentage of cells that internalized S. aureus
and the MFI were determined by flow cytometry. c, left panels, Transmission electron
microscopy of live S. aureus in WT, Ice−/− and Nlrp3−/− BM macrophage cell lines 8 hours
after infection. Right panels, the subcellular localization and number of intra-vacuolar S.
aureus was quantified by counting. Red, cytosolic bacteria, Other colours correspond to
different numbers of intra-vacuolar bacteria in each phagosome. d, S. aureus (MOI: 5)
survival in WT, Ice−/− and Nlrp3−/− BMDM was determined by gentamicin protection
assays 20 hours after infection. e-g, IL-6 production by peritoneal macrophages (e, f) and
BMDM (g) after S. aureus infection (MOI: 10). Black bars in e-g are control and white bars
are e, Bafilomycin A (100 nM); f, YVAD (100 μM); g, Ice−/−. h-i Antigen cross-
presentation of ovalbumin (OVA) to CD8+ OT-I T cells by (h) BM macrophages, control
(black bars) or pretreated with YVAD (100 μM) (white bars), internalized soluble OVA or
OVA conjugated to HI S. aureus (MOI: 10) and by (i) WT (black bars) and Ice−/− (white
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tbars) BM macrophage cell lines, internalized soluble OVA or OVA conjugated to beads (10
beads/ cell) or HI S. aureus (MOI:10). Left panels % divided CD8+ T cells, right, FACS
histograms. (a,b e-i) Data are representative of three independent experiments (mean ± s.d).
(c) Data is representative of two independent experiments (d) Data are presented as a pool of
three experiments (mean ± s.e.m), * p<0.01, **p<0.001 by Student’s t-test.
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